Recursion Pharmaceuticals, Inc.(RXRX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

RXRX Recursion Pharmaceuticals, Inc.

Market Closed 01-31 16:00:00 EST

7.24

-0.45

-5.85%

盘后7.25

+0.01+0.14%

19:59 EST

High7.96	Low7.15	Vol21.32M
Open7.91	D1 Closing7.69	Amplitude10.53%
Mkt Cap2.86B	Tradable Cap2.58B	Total Shares394.42M
T/O160.32M	T/O Rate5.99%	Tradable Shares356.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"RXRX","market":"US","secType":"STK","nameCN":"Recursion Pharmaceuticals, Inc.","latestPrice":7.24,"timestamp":1738357200000,"preClose":7.69,"halted":0,"volume":21322244,"hourTrading":{"tag":"盘后","latestPrice":7.2499,"preClose":7.24,"latestTime":"19:59 EST","volume":329205,"amount":2388344.283,"timestamp":1738371585764},"delay":0,"floatShares":356000000,"shares":394417876,"eps":-1.537942,"marketStatus":"Market Closed","change":-0.45,"latestTime":"01-31 16:00:00 EST","open":7.91,"high":7.96,"low":7.15,"amount":160323722.382252,"amplitude":0.105332,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.537942,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1738573200000},"marketStatusCode":7,"adr":0,"listingDate":1618545600000,"exchange":"NASDAQ","adjPreClose":7.69,"preHourTrading":{"tag":"盘前","latestPrice":7.92,"preClose":7.69,"latestTime":"09:29 EST","volume":400899,"amount":3180916.2777420003,"timestamp":1738333799999},"postHourTrading":{"tag":"盘后","latestPrice":7.2499,"preClose":7.24,"latestTime":"19:59 EST","volume":329205,"amount":2388344.283,"timestamp":1738371585764},"volumeRatio":1.1864718526833846,"impliedVol":0.9436,"impliedVolPercentile":0.7689},"requestUrl":"/m/hq/s/RXRX/tweets","defaultTab":"tweets","newsList":[{"id":"2507670581","title":"Recursion Pharmaceuticals call volume above normal and directionally bullish","url":"https://stock-news.laohu8.com/highlight/detail?id=2507670581","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507670581?lang=en_us&edition=fundamental","pubTime":"2025-01-31 03:45","pubTimestamp":1738266316,"startTime":"0","endTime":"0","summary":"Bullish option flow detected in Recursion Pharmaceuticals (RXRX) with 16,974 calls trading, 1.0x expected, and implied vol increasing over 12 point...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/recursion-pharmaceuticals-call-volume-above-normal-and-directionally-bullish-19?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/recursion-pharmaceuticals-call-volume-above-normal-and-directionally-bullish-19?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4548","BK4539","BK4139","RXRX"],"gpt_icon":0},{"id":"2507624257","title":"Institutional owners may consider drastic measures as Recursion Pharmaceuticals, Inc.'s (NASDAQ:RXRX) recent US$130m drop adds to long-term losses","url":"https://stock-news.laohu8.com/highlight/detail?id=2507624257","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507624257?lang=en_us&edition=fundamental","pubTime":"2025-01-30 22:17","pubTimestamp":1738246659,"startTime":"0","endTime":"0","summary":"Given the large stake in the stock by institutions, Recursion Pharmaceuticals' stock price might be vulnerable to their trading decisions. A total of 11 investors have a majority stake in the company with 50% ownership. Ownership research along with  analyst forecasts data  help provide a good understanding of opportunities in a stock. To get a sense of who is truly in control of Recursion Pharmaceuticals, Inc. , it is important to understand the ownership structure of the business. With 66% stake, institutions possess the maximum shares in the company. In other words, the group stands to gain the most  from their investment into the company.Investors should note that institutions actually own more than half the company, so they can collectively wield significant power. Recursion Pharmaceuticals is not owned by hedge funds. ARK Investment Management LLC is currently the largest shareholder, with 8.3% of shares outstanding. Baillie Gifford & Co. is the second largest shareholder owning ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/institutional-owners-may-consider-drastic-141739280.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4585","NDAQ","BK4588","TQQQ","BK4139","SQQQ","QLD","BK4539","LU2095319765.USD","RXRX","IE00BGHQF748.EUR","TSYW.SI","IE00B64PRP62.GBP","BK4112","LU2210149790.SGD","LU2210150020.SGD","NVIW.SI","NQmain","QID","USJW.SI","PSQ","IE00B3QW5Z07.USD","MNQmain","BK4548","USAW.SI",".IXIC","IE00BKPKM429.USD"],"gpt_icon":1},{"id":"1131203822","title":"Stock Track | Recursion Pharmaceuticals Plummets 5.05% Amid AI Market Volatility and Healthcare Tech Concerns","url":"https://stock-news.laohu8.com/highlight/detail?id=1131203822","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131203822?lang=en_us&edition=fundamental","pubTime":"2025-01-30 03:02","pubTimestamp":1738177364,"startTime":"0","endTime":"0","summary":"Recursion Pharmaceuticals, Inc.  stock experienced a 5.05% plummet in the intraday trading session on Wednesday, potentially driven by broader market concerns and volatility surrounding the artificial intelligence  industry.The biotech company, which focuses on AI-driven drug discovery, has garnered attention for its involvement in the rapidly growing AI healthcare market. However, recent developments, such as the introduction of DeepSeek's new AI model, have fueled market jitters and an \"overre","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Stock Track | Recursion Pharmaceuticals Plummets 5.05% Amid AI Market Volatility and Healthcare Tech Concerns","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["RXRX"],"gpt_icon":1},{"id":"2507012682","title":"Is Recursion Pharmaceuticals (RXRX) the Cheap AI Stock to Buy in 2025?","url":"https://stock-news.laohu8.com/highlight/detail?id=2507012682","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507012682?lang=en_us&edition=fundamental","pubTime":"2025-01-29 19:45","pubTimestamp":1738151155,"startTime":"0","endTime":"0","summary":"We recently published a list of 12 Cheap AI Stocks to Buy in 2025. In this article, we are going to take a look at where Recursion Pharmaceuticals, Inc.  stands against other cheap AI stocks to buy in 2025.However, DeepSeek’s introduction shocked the U.S. companies after it released a new AI model, a much better alternative to GPT-4. DeepSeek claims to have designed the AI model in just two months and at around under $6 million using Nvidia’s less-advanced H800 chips, as reported by Reuters on January 27. Since the news broke out, NVIDIA Corporation  shares have plunged over 16%, wiping away $600 billion in market capitalization, the biggest one-day loss in U.S. history.However, Moorhead also addressed the U.S. market drop as an “overreaction.”“I think the market overall should be going crazy because [this is the] uplift of what we were looking for [from AI],”said Moorhead. He added that the investors’ focus should be on the progress in inference.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/recursion-pharmaceuticals-rxrx-cheap-ai-114555431.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NVDY","NVD2.UK","LU0198837287.USD","USJW.SI","LU2092627202.USD","NVDA","LU2420271590.USD","NVIW.SI","LU2097344357.USD","SQQQ","LU1119994496.HKD","PSQ","TSYW.SI","2NVD.UK","QLD","NVDD","LU1989772840.SGD","NVD","LU0061474705.USD","NVDU","IE00BDRTCR15.USD","LU0957791311.USD","NVDS","LU0238689110.USD","BK4554","BK4581","NVDS.UK","3NVD.UK","LU0861579265.USD","RXRX","NVD3.UK",".IXIC","IE00B5949003.HKD","TQQQ","LU0215105999.USD","LU0276348264.USD","USAW.SI","LU2087625088.SGD","SNVD.UK","LU1435385759.SGD","QID","LU2264538146.SGD","MNQmain","NQmain","IE00BJLML261.HKD","BK4527","LU2265009873.SGD"],"gpt_icon":1},{"id":"2506558889","title":"Recursion Pharmaceuticals call volume above normal and directionally bullish","url":"https://stock-news.laohu8.com/highlight/detail?id=2506558889","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506558889?lang=en_us&edition=fundamental","pubTime":"2025-01-28 01:25","pubTimestamp":1737998706,"startTime":"0","endTime":"0","summary":"Bullish option flow detected in Recursion Pharmaceuticals (RXRX) with 20,041 calls trading, 1.8x expected, and implied vol increasing over 2 points...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/recursion-pharmaceuticals-call-volume-above-normal-and-directionally-bullish-18?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/recursion-pharmaceuticals-call-volume-above-normal-and-directionally-bullish-18?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4548","RXRX","BK4539","BK4139"],"gpt_icon":0},{"id":"1132574576","title":"Nvidia-Linked Stocks Rout; NBIS Plunged 27%, APLD Down 11%","url":"https://stock-news.laohu8.com/highlight/detail?id=1132574576","media":"Tiger Newspress","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132574576?lang=en_us&edition=fundamental","pubTime":"2025-01-27 22:47","pubTimestamp":1737989277,"startTime":"0","endTime":"0","summary":"Nvidia-Linked Stocks rout; NBIS Plunged 27%, APLD Down 11%.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"3f04465c50e67cf4ba19a42b0d93bb21","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARM","TM","AUR","NVDA","INVZ","MU","NNOX","NBIS","APLD","RXRX","SERV","ARBE","CRNC","SOUN"],"gpt_icon":0},{"id":"2506895040","title":"Recursion Pharmaceuticals (RXRX): Industrializing Drug Discovery with AI Amid J.P. Morgan’s ‘Neutral’ Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2506895040","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506895040?lang=en_us&edition=fundamental","pubTime":"2025-01-25 01:12","pubTimestamp":1737738736,"startTime":"0","endTime":"0","summary":"We recently compiled a list of the Top 10 Medical AI Stocks on Wall Street's Radar.In this article, we are going to take a look at where Recursion Pharmaceuticals  stands against the other medical AI stocks.Investments in the global healthcare industry have ramped up sharply since the COVID-19 pandemic. With the advent of artificial intelligence , the industry witnessed a rapid transformation in early disease detection, genomic research, drug discovery, clinical processes, and treatment efficacy prediction.According to a 2023 PwC report, the AI market in healthcare was valued at $11 billion and is expected to grow to $188 billion by 2030. On January 21st, Oracle Co-founder Larry Ellison said during a White House speech that AI plays an integral role in early cancer detection and vaccine development. He highlighted how AI could help detect tiny tumor fragments and assist in gene-sequencing malignancies for the development of mRNA vaccines at a rapid speed for customized cancer treatment","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/recursion-pharmaceuticals-rxrx-industrializing-drug-171216694.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["RXRX"],"gpt_icon":1},{"id":"2505048672","title":"Recursion Pharmaceuticals (RXRX) Moves 8.9% Higher: Will This Strength Last?","url":"https://stock-news.laohu8.com/highlight/detail?id=2505048672","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505048672?lang=en_us&edition=fundamental","pubTime":"2025-01-23 22:45","pubTimestamp":1737643500,"startTime":"0","endTime":"0","summary":"Recursion Pharmaceuticals  shares ended the last trading session 8.9% higher at $7.49. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 5% loss over the past four weeks.The sudden rise in the stock price was observed after President Donald Trump announced a $500 billion project to develop and expand AI infrastructure, at his inauguration event on Monday. Investors likely anticipate that Recursion, being a Tech-Bio company that utilizes AI models in drug discovery, would benefit from the project.For Recursion Pharmaceuticals, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on RXRX going forward to see if this recent jump can turn into more strength down the road.Recursion Pharmaceuticals belongs to the Zacks Medic","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/recursion-pharmaceuticals-rxrx-moves-8-144500353.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","RXRX","ENTA","BK4548","BK4539"],"gpt_icon":1},{"id":"2505032159","title":"Why Recursion Pharmaceuticals, Inc. (RXRX) Soared on Wednesday","url":"https://stock-news.laohu8.com/highlight/detail?id=2505032159","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505032159?lang=en_us&edition=fundamental","pubTime":"2025-01-23 12:01","pubTimestamp":1737604905,"startTime":"0","endTime":"0","summary":"Wall Street’s main indices ended firmer on Wednesday as share prices remained boosted by positive catalysts from President Donald Trump's inauguration coupled with better-than-expected earnings performance.The Dow rose by 0.30 percent, the S&P 500 grew 0.61 percent, while the Nasdaq Composite increased 1.28 percent.Meanwhile, 10 companies under mixed sectors mirrored Wall Street's gains. In this article, we will look at which companies led the rally and explore the reasons behind their impressive performance.To come up with Wednesday's top gainers, we considered only the stocks with at least $2 billion in market capitalization and $5 million in daily trading volume.A pharmacist in a hospital pharmacy stands next to a row of various drug containers.Recursion Pharmaceuticals, Inc. , a biotechnology company, reported an 8.87-percent increase in its share prices on Wednesday, a third consecutive day, to finish at $7.49 each.According to analysts, companies utilizing artificial intelligence","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/why-recursion-pharmaceuticals-inc-rxrx-040145483.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["QLD","RXRX","NVIW.SI","BK4139","NQmain",".IXIC","SQQQ","MNQmain","USJW.SI","BK4548","PSQ","TQQQ","BK4539","QID","USAW.SI","TSYW.SI"],"gpt_icon":1},{"id":"2505778423","title":"Why Drug Developers That Utilize AI, Including SDGR and RXRX, Are Jumping","url":"https://stock-news.laohu8.com/highlight/detail?id=2505778423","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505778423?lang=en_us&edition=fundamental","pubTime":"2025-01-23 00:29","pubTimestamp":1737563372,"startTime":"0","endTime":"0","summary":"Pharmaceutical firms that specialize in utilizing AI to speed up the drug discovery process are soaring today. The rally comes after an Alphabet (GOOG,GOOGL) executive yesterday reported that the firm","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/why-drug-developers-utilize-ai-162932847.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2028103732.USD","IE00BYQQ9H92.USD","IE00B3S45H60.SGD","BK4581","LU2023250504.SGD","LU1201861249.SGD","USJW.SI","LU0965509101.SGD","LU1037948541.HKD","LU1868836914.USD","LU2087625088.SGD","LU2242650005.HKD","LU0353189680.USD","LU2065170008.USD","LU0957808578.USD","ICAD","GOOGL","LU0211331839.USD","LU0345769631.USD","GOOG","LU0068578508.USD","LU2191332357.HKD","LU2592432038.USD","LU1267930730.SGD","LU1366192091.USD","LU0302445910.USD","BK4587","LU0215105999.USD","LU1852331112.SGD","LU2023251221.USD","LU1116320737.USD","LU2087621335.USD","LU0742534661.SGD","IE00BZ1G4Q59.USD","IE00BJJMRY28.SGD","LU1934455863.HKD","LU0094547139.USD","LU0823421416.USD","LU1267930227.SGD","NVS","SDGR","IE00BFSS7M15.SGD","LU0642271901.SGD","LU1043141123.HKD","LU0345768153.USD","RXRX","LU0234572021.USD","LU0708995401.HKD","LU0965508806.USD","LU1489326972.SGD"],"gpt_icon":1},{"id":"1125789942","title":"Stock Track | Recursion Pharmaceuticals Soars 16.40% on Bullish Options Activity","url":"https://stock-news.laohu8.com/highlight/detail?id=1125789942","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125789942?lang=en_us&edition=fundamental","pubTime":"2025-01-22 23:50","pubTimestamp":1737561023,"startTime":"0","endTime":"0","summary":"Recursion Pharmaceuticals, Inc.  stock soared 16.40% in the intraday trading session on Wednesday, fueled by bullish options activity.According to the available news, there was a significant surge in call option trading volume for RXRX, with 40,958 calls trading, approximately 9 times the expected volume. Additionally, the implied volatility increased by over 14 points, indicating heightened interest and expectations for further upside in the stock price.While the specific reasons for the bullis","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Stock Track | Recursion Pharmaceuticals Soars 16.40% on Bullish Options Activity","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["RXRX"],"gpt_icon":1},{"id":"2505224287","title":"Recursion Pharmaceuticals call volume above normal and directionally bullish","url":"https://stock-news.laohu8.com/highlight/detail?id=2505224287","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505224287?lang=en_us&edition=fundamental","pubTime":"2025-01-22 23:45","pubTimestamp":1737560709,"startTime":"0","endTime":"0","summary":"Bullish option flow detected in Recursion Pharmaceuticals (RXRX) with 40,958 calls trading, 9x expected, and implied vol increasing over 14 points ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/recursion-pharmaceuticals-call-volume-above-normal-and-directionally-bullish-15?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/recursion-pharmaceuticals-call-volume-above-normal-and-directionally-bullish-15?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RXRX","BK4139","BK4539","BK4548"],"gpt_icon":0},{"id":"2504481882","title":"Recursion Pharmaceuticals, Inc. (RXRX): Revolutionizing Drug Discovery with AI and Strategic Collaborations for Strong Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2504481882","media":"Insider Monkey","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504481882?lang=en_us&edition=fundamental","pubTime":"2025-01-19 04:43","pubTimestamp":1737233005,"startTime":"0","endTime":"0","summary":"We recently compiled a list of the Blackrock's 30 Most Important AI Stocks.In this article, we are going to take a look at where Recursion Pharmaceuticals, Inc.  stands against the other AI stocks.In the third quarter of 2024, investment titan Blackrock released a commentary on the market outlook for artificial intelligence heading into the closing months of the year, stressing that investors were becoming cautious about the scale of AI spending by tech firms and thus diversifying investments into energy, utilities, real estate, and resources tied to AI infrastructure . Following this warning, in September 2024, BlackRock, in collaboration with Microsoft, Global Infrastructure Partners, and MGX, announced a new AI partnership aimed at investing in data centers and supporting power infrastructure. This initiative was part of a larger strategy by the investment firm to enhance American competitiveness in AI while meeting the growing need for energy infrastructure to power economic growth","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/recursion-pharmaceuticals-inc-rxrx-revolutionizing-204325597.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0314104364.USD","LU2065170008.USD","BK4535","LU0426417589.USD","LU2191332357.HKD","LU1066053197.SGD","LU1935042991.SGD","LU0820561909.HKD","LU2092627202.USD","LU2023250843.SGD","BLK","LU0496365809.HKD","LU0823421333.USD","LU1119994496.HKD","LU2505996681.GBP","LU2125154778.USD","RXRX","LU0127658192.USD","LU2065171311.SGD","IE00BYXW3230.USD","BK4592","LU1629891620.HKD","LU0708994859.HKD","LU0640476718.USD","LU0792757196.USD","LU1633808545.USD","LU1868837136.USD","LU2357305700.SGD","LU1496350171.SGD","LU2237443382.USD","LU2244417387.USD","LU0731783048.USD","LU1481011671.HKD","LU1914381329.SGD","BK4514","LU2271345857.HKD","IE0004091025.USD","LU2462157665.USD","LU0154236417.USD","BK4139","LU2491049909.HKD","BK4561","IE00B1BXHZ80.USD","SG9999015945.SGD","LU2237443622.USD","LU0708995401.HKD","LU1145028129.USD","LU0320765489.SGD","LU0648001328.SGD"],"gpt_icon":1},{"id":"2504130059","title":"Is Recursion Pharmaceuticals Stock a Buy?","url":"https://stock-news.laohu8.com/highlight/detail?id=2504130059","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504130059?lang=en_us&edition=fundamental","pubTime":"2025-01-17 17:47","pubTimestamp":1737107220,"startTime":"0","endTime":"0","summary":"Recursion Pharmaceuticals has a flashy drug development platform.It has a lot to prove about whether that platform's use of AI is helpful.Some power players have backed it with significant commitments.Everything touching artificial intelligence  is hot right now, so it's no surprise that the biotech Recursion Pharmaceuticals  could be positioned to ride the ongoing wave of hype to great heights. Between its AI-first approach to designing new drugs and its positioning as a valuable collaborator for other companies, the company is worth paying attention to at a minimum.But does that make the stock worth buying right now, given the considerable uncertainties surrounding the actual merit of its AI-heavy approach?","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/01/17/is-recursion-pharmaceuticals-stock-a-buy/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["BK4139","BK4539","BK4548","RXRX"],"gpt_icon":1},{"id":"2503889539","title":"Recursion Pharmaceuticals (RXRX) Rises Yet Lags Behind Market: Some Facts Worth Knowing","url":"https://stock-news.laohu8.com/highlight/detail?id=2503889539","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503889539?lang=en_us&edition=fundamental","pubTime":"2025-01-16 06:50","pubTimestamp":1736981422,"startTime":"0","endTime":"0","summary":"In the latest trading session, Recursion Pharmaceuticals  closed at $6.42, marking a +1.58% move from the previous day. This move lagged the S&P 500's daily gain of 1.83%. On the other hand, the Dow registered a gain of 1.65%, and the technology-centric Nasdaq increased by 2.45%.Shares of the biotechnology company witnessed a loss of 11.24% over the previous month, trailing the performance of the Medical sector with its loss of 3.48% and the S&P 500's loss of 3.31%.The upcoming earnings release of Recursion Pharmaceuticals will be of great interest to investors. It is anticipated that the company will report an EPS of -$0.35, marking a 12.5% rise compared to the same quarter of the previous year. In the meantime, our current consensus estimate forecasts the revenue to be $26.7 million, indicating a 145.18% growth compared to the corresponding quarter of the prior year.Furthermore, it would be beneficial for investors to monitor any recent shifts in analyst projections for Recursion Pha","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/recursion-pharmaceuticals-rxrx-rises-yet-225022250.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4548","BK4139","BK4539","RXRX"],"gpt_icon":1},{"id":"1196265672","title":"Stock Track | Recursion Pharmaceuticals Soars 7.75% After Rallying on Fed Rate-Cut Hopes","url":"https://stock-news.laohu8.com/highlight/detail?id=1196265672","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1196265672?lang=en_us&edition=fundamental","pubTime":"2025-01-15 23:32","pubTimestamp":1736955144,"startTime":"0","endTime":"0","summary":"Recursion Pharmaceuticals, Inc.  stock soared 7.75% during Wednesday's intraday trading session, riding on a broader rally in technology and AI-related stocks. The surge came after cooler-than-expected US inflation data bolstered expectations that the Federal Reserve would continue cutting interest rates this year.The biotech company's shares got a boost as investors piled into stocks linked to Nvidia, the leading provider of chips used in artificial intelligence applications. Recursion's AI-ena","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Stock Track | Recursion Pharmaceuticals Soars 7.75% After Rallying on Fed Rate-Cut Hopes","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["RXRX"],"gpt_icon":1},{"id":"1146717787","title":"Nvidia-Linked Stocks Surge As Easing Inflation Boosts Fed Rate-Cut Bets","url":"https://stock-news.laohu8.com/highlight/detail?id=1146717787","media":"Tiger Newspress","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146717787?lang=en_us&edition=fundamental","pubTime":"2025-01-15 23:30","pubTimestamp":1736955058,"startTime":"0","endTime":"0","summary":"Wall Street breathed a sigh of relief after a surprise slowdown in inflation spurred a stock rally and a plunge in bond yields, reinforcing bets the Federal Reserve is on track to keep cutting rates this year.The US CPI rose in December by less than forecast, reinvigorating bets the Fed will cut rates sooner than previously thought. Swap traders are now back to fully pricing in a rate cut by July. That was a quick shift after hotter-than-estimated jobs data spurred bets the central bank would on","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RXRX","SOUN","SERV","APLD","INVZ","AUR","MU","ARM","NNOX","ARBE","TM","NVDA","CRNC","NBIS"],"gpt_icon":1},{"id":"1174400011","title":"24H｜Quantum Computing Stocks Surge; QMCO up 17%; D-Wave Quantum Rises 10%; Robotics Stocks, Drone Makers Jump","url":"https://stock-news.laohu8.com/highlight/detail?id=1174400011","media":"Tiger Newspress","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174400011?lang=en_us&edition=fundamental","pubTime":"2025-01-15 10:06","pubTimestamp":1736906814,"startTime":"0","endTime":"0","summary":"Data center operator Applied Digital on Tuesday posted a smaller-than-expected loss for the second quarter, helped by increased demand for high-performance data center infrastructure and cloud services business.Applied Digital sharesl slipped 6% in overnight trading.Bill Stone, chief investment officer at Glenview Trust, told Barron's Tuesday that quantum computing may be \"the next big thing,\" but it is currently in speculation territory.During overnight trading, there was a chorus of support fo","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"4cc9f991e1675ba35ec64a6c1ca3142f","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UMAC","PDYN","NNOX","TM","RCAT","CRNC","ARQQ","GOOG","RGTI","IRBT","LAES","RXRX","SES","QBTS","ONDS","NBIS","QMCO","HOLO","MBOT","GFAI","ARBE","SERV","KITT","IONQ","RR","ARM","APLD","NVDA","MU","GOOGL","AVAV","LFWD","STXS","SOUN","INVZ","QUBT","SYM","AUR","PRZO","KTOS"],"gpt_icon":1},{"id":"2503527022","title":"3 Reasons Nvidia Stock Is a Forever Buy and Hold","url":"https://stock-news.laohu8.com/highlight/detail?id=2503527022","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503527022?lang=en_us&edition=fundamental","pubTime":"2025-01-14 20:00","pubTimestamp":1736856000,"startTime":"0","endTime":"0","summary":"Nvidia's data center chip revenues are projected to surge as the market expands to $390.65 billion by 2030.The company's transformation extends beyond GPUs into networking, software, and strategic investments in AI-driven startups.With a forward P/E of 31.7, Nvidia's premium valuation reflects its market dominance and growth potential in physical AI and robotics.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/01/14/3-reasons-nvidia-stock-is-a-forever-buy-and-hold/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["NVDD","2NVD.UK","LU1674673428.USD","TQQQ","BK4529","RXRX","IE00BQXX3C00.GBP","LU1066051811.HKD","LU0965509010.AUD","LU1244550221.USD","APLD","NVD3.UK","NVD","TSYW.SI","LU2458330169.SGD","SERV","IE0005OL40V9.USD","LU0494093205.USD","IE00B19Z8X17.USD",".IXIC","LU0203202063.USD","NVDY","BK4532","NQmain","IE0034235303.USD","NVDX","SNVD.UK","USAW.SI","USJW.SI","NVDS.UK","LU2552382215.SGD","NVDA","IE00BK4W5L77.USD","LU1699723380.USD","PSQ","IE00BK4W5M84.HKD","BK4554","NVDU","LU2237438978.USD","NVIW.SI","QID","QLD","BK4543","3NVD.UK","MNQmain","NVDS","SQQQ","NVD2.UK"],"gpt_icon":1},{"id":"1126840180","title":"24H｜Nvidia-Linked Stocks Soar in Overnight Trading with SERV up 8%; Tesla Jumps 2%; DXYZ Rises 6%","url":"https://stock-news.laohu8.com/highlight/detail?id=1126840180","media":"Tiger Newspress","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126840180?lang=en_us&edition=fundamental","pubTime":"2025-01-14 10:05","pubTimestamp":1736820345,"startTime":"0","endTime":"0","summary":"Nvidia-linked stocks soar in overnight trading with CRNC up 7% and SERV up 6%.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"3c2f82606314d9cf6e7f7a4171a5fb4a","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLSK","ARBE","SERV","INVZ","AUR","DXYZ","TM","BTBT","BITO","CRNC","TSLA","MSTR","NNOX","MARA","MU","ARM","NBIS","RXRX","CAN","GBTC","RIOT","KBH","NVDA","APLD","SOUN","COIN"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.recursion.com","stockEarnings":[{"period":"1week","weight":-0.0123},{"period":"1month","weight":0.071},{"period":"3month","weight":0.1312},{"period":"6month","weight":0.0313},{"period":"1year","weight":-0.2419},{"period":"ytd","weight":0.071}],"compareEarnings":[{"period":"1week","weight":-0.0101},{"period":"1month","weight":0.0269},{"period":"3month","weight":0.0539},{"period":"6month","weight":0.1293},{"period":"1year","weight":0.2302},{"period":"ytd","weight":0.0269}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase 2 clinical trial to treat cerebral cavernous malformation; REC-2282, which is in Phase 2/3 clinical trial for the treatment of neurofibromatosis type 2; REC-4881, which is in Phase 2 clinical trial to treat familial adenomatous polyposis; REC-3964, which is in Phase 1 clinical trial to treat Clostridioides difficile infection; and REC-4881, which is in Phase 1b/2 clinical trial to treat AXIN1 or APC mutant cancers. Its preclinical stage product includes RBM39 to treat HR-proficient ovarian cancer; REC-64151 for the treatment of immune checkpoint resistance; and Anti-PD-(L)1, an orally bioavailable small molecule to improve sensitivity to immune checkpoint inhibitors in non-small cell lung cancer and additional tumors. The company has collaboration and agreement with Bayer AG; the University of Utah Research Foundation; Ohio State Innovation Foundation; Chromaderm, Inc.; Roche & Genentech; and Takeda Pharmaceutical Company Limited. Recursion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Salt Lake City, Utah.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.050758},{"month":2,"riseRate":0.333333,"avgChangeRate":0.111205},{"month":3,"riseRate":0,"avgChangeRate":-0.262334},{"month":4,"riseRate":0,"avgChangeRate":-0.211528},{"month":5,"riseRate":0.5,"avgChangeRate":0.168429},{"month":6,"riseRate":0.5,"avgChangeRate":0.118076},{"month":7,"riseRate":0.75,"avgChangeRate":0.213595},{"month":8,"riseRate":0.25,"avgChangeRate":-0.10569},{"month":9,"riseRate":0.25,"avgChangeRate":-0.072683},{"month":10,"riseRate":0,"avgChangeRate":-0.131747},{"month":11,"riseRate":0.5,"avgChangeRate":0.076362},{"month":12,"riseRate":0.25,"avgChangeRate":0.027925}],"exchange":"NASDAQ","name":"Recursion Pharmaceuticals, Inc.","nameEN":"Recursion Pharmaceuticals, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.30.2","shortVersion":"4.30.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Recursion Pharmaceuticals, Inc.(RXRX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Recursion Pharmaceuticals, Inc.(RXRX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Recursion Pharmaceuticals, Inc.,RXRX,Recursion Pharmaceuticals, Inc.股票,Recursion Pharmaceuticals, Inc.股票老虎,Recursion Pharmaceuticals, Inc.股票老虎国际,Recursion Pharmaceuticals, Inc.行情,Recursion Pharmaceuticals, Inc.股票行情,Recursion Pharmaceuticals, Inc.股价,Recursion Pharmaceuticals, Inc.股市,Recursion Pharmaceuticals, Inc.股票价格,Recursion Pharmaceuticals, Inc.股票交易,Recursion Pharmaceuticals, Inc.股票购买,Recursion Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Recursion Pharmaceuticals, Inc.(RXRX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Recursion Pharmaceuticals, Inc.(RXRX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}